Company Profile

ALBERT DAVID LIMITED, ACTIVE SINCE 1938, HAS MANUFACTURING UNITS IN KOLKATA AND GHAZIABAD, PRODUCING A WIDE RANGE OF PHARMACEUTICAL PRODUCTS INCLUDING LVPS, SVPS, AND APIS. WITH A TURNOVER OF USD 45 MILLION (FY 2023–24), IT RANKS AMONG INDIA'S TOP 60 PHARMA FIRMS BY PRESCRIPTION SALES. ADL SPECIALIZES IN STERILE LIQUIDS, BFS TECHNOLOGY, NUTRACEUTICALS, GASTRO, WOMEN'S HEALTH, OPHTHALMICS, WOUND CARE, AND ANTI-LEISHMANIASIS. ITS GHAZIABAD PLANT MANUFACTURES SVPS (2–50 ML PE) AND LVPS (100–1000 ML, GLASS/PE). KOLKATA’S API UNIT WAS PREVIOUSLY USFDA & EDQM APPROVED. ADL SUPPLIES SODIUM STIBOGLUCONATE TO WHO, MSF & IDA AND IS PURSUING WHO PQ. ITS R&D PRODUCT PLACENTREX® (PLACENTAL EXTRACT) IS AVAILABLE IN INJECTABLE, GEL, AND OINTMENT FORMS. ADL AIMS TO EXPAND GLOBALLY WITH QUALITY, AFFORDABLE MEDICINES. CONTACT: RUSHABH.THAKKAR@ADLINDIA.IN | WWW.ALBERTDAVIDINDIA.COM